Dr Sylvain Durrleman has 25 years of Global Clinical Development in the pharmaceutical industry and a track record of bringing several key drugs to the market.
Dr. Durrleman was for many years a Vice-President and member of Sanofi-Aventis’ Executive Committee for Research & Development (R&D). During his tenure at Sanofi he has been responsible for many aspects of Clinical Development, as Vice-President for Global Clinical Development, Clinical Operations, and head of Biostatistics and Data Management.
Prior to joining the pharmaceutical Industry, Dr. Durrleman was a Cancer Expert at the Biometric Research Branch of the Division of Cancer Treatment of the National Cancer Institute (National Institutes of Health, Bethesda, MD). He received his medical degree from the Université René Descartes, Necker Medical School, Paris, France and completed his residency at the Assistance Publique des Hopitaux de Paris. He obtained his doctorate (DEA/PhD) in Biomathematics from the Université Paris VII, and then worked as an epidemiological researcher with INSERM in France.
Dr Durrleman’s career has been devoted to bring several products to market that have changed healthcare, and is today committed to use his in-depth experience in clinical development to help make Lixoft a reference company in its field.